- NEWS AND VIEWS
Cancer cells stock up in lymph vessels to survive
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 585, 36-37 (2020)
doi: https://doi.org/10.1038/d41586-020-02383-5
References
Leiter, U. et al. Lancet Oncol. 17, 757–767 (2016).
Faries, M. B. et al. N. Engl. J. Med. 376, 2211–2222 (2017).
Pereira, E. R. et al. Science 359, 1403–1407 (2018).
Brown, M. et al. Science 359, 1408–1411 (2018).
Ubellacker, J. M. et al. Nature 585, 113–118 (2020).
Vanharanta, S. & Massagué, J. Cancer Cell 24, 410–421 (2013).
Mehlen, P. & Puisieux, A. Nature Rev. Cancer 6, 449–458 (2006).
Elia, I., Doglioni, G. & Fendt, S.-M. Trends Cell Biol. 28, 673–684 (2018).
Faubert, B., Solmonson, A. & DeBerardinis, R. J. Science 368, eaaw5473 (2020).
Hadian, K. & Stockwell, B. R. Cell 181, 1188 (2020).
Competing Interests
S.-M.F. has received funding from Bayer AG, Merck and Black Belt Therapeutics, and has consulted for Fund+.